Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Arrhythmias

  Free Subscription


01.09.2025

1 Am Heart J
1 Am J Cardiol
3 Circ Arrhythm Electrophysiol
2 Circ Cardiovasc Qual Outcomes
1 Circ Res
1 Clin Cardiol
4 Eur Heart J
1 Heart
1 Int J Cardiol
1 J Am Coll Cardiol
1 J Cardiovasc Electrophysiol
2 J Interv Card Electrophysiol
1 N Engl J Med
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am Heart J

  1. TAMIRISA KP, Sanchez JE, La Fazia VM, Gianni C, et al
    Pulsed field ablation-related hemoglobinuria and acute kidney injury: Insights and strategies for effective management.
    Am Heart J. 2025;290:339-346.
    PubMed         Abstract available


    Am J Cardiol

  2. VERDINO RJ
    Improving Functional Mitral Regurgitation by Catheter Ablation of Atrial Fibrillation - Yet Another Benefit of this Widely Performed Procedure.
    Am J Cardiol. 2025 Aug 27:S0002-9149(25)00502.
    PubMed        


    Circ Arrhythm Electrophysiol

  3. MIYAZAKI S, Nitta J, Nakamura K, Kobori A, et al
    Two Different Cryoballoon Systems for Treatment of Paroxysmal Atrial Fibrillation: Results From the CONTRAST-CRYO Trial.
    Circ Arrhythm Electrophysiol. 2025 Aug 26:e014041.
    PubMed        

  4. ANDRADE JG, Aguilar M, Bennett RG, Benali K, et al
    Relationship Between Time-to-First Atrial Tachyarrhythmia Recurrence and Atrial Fibrillation Burden: Implications for Trial Design.
    Circ Arrhythm Electrophysiol. 2025 Aug 28:e013971.
    PubMed         Abstract available

  5. LI C, Zhao Y, Ju R, Liu C, et al
    Cryoballoon Roof Line and Pulmonary Vein Isolation for Persistent Atrial Fibrillation: A Randomized Trial.
    Circ Arrhythm Electrophysiol. 2025 Aug 28:e013826.
    PubMed        


    Circ Cardiovasc Qual Outcomes

  6. WINSTEN AK, Langen V, Airaksinen KEJ, Teppo K, et al
    Estimating the Stroke Risk Threshold for Initiating Non-Vitamin K Antagonist Oral Anticoagulation in Atrial Fibrillation: Markov Decision Model Analysis.
    Circ Cardiovasc Qual Outcomes. 2025 Aug 27:e012090.
    PubMed         Abstract available

  7. KIM DH, Ko D, Singer DE, Cervone A, et al
    Clinical Outcomes of Switching From Warfarin to Apixaban or Rivaroxaban in Patients With Atrial Fibrillation: A Nationwide Multidatabase Study.
    Circ Cardiovasc Qual Outcomes. 2025 Aug 27:e011890.
    PubMed         Abstract available


    Circ Res

  8. GONANO LA, Kinns AM, Bergan-Dahl A, Louch WE, et al
    Interplay Between Ryanodine Receptor Arrangement and Function: Implications for (Patho)physiological Control of Calcium Release.
    Circ Res. 2025;137:902-923.
    PubMed         Abstract available


    Clin Cardiol

  9. KATAOKA N, Imamura T
    Atrial Fibrillation and Obstructive Sleep Apnea: Do Mortality Trends Reflect Disease Burden or Diagnostic Gaps?
    Clin Cardiol. 2025;48:e70200.
    PubMed        


    Eur Heart J

  10. SVENNBERG E, Freedman B, Andrade JG, Anselmino M, et al
    Recent-onset atrial fibrillation: challenges and opportunities.
    Eur Heart J. 2025 Aug 28:ehaf478. doi: 10.1093.
    PubMed         Abstract available

  11. STEGMANN T, Joundi RA, Srivastava A, Sinnecker T, et al
    Atrial fibrillation and atherosclerosis cause different vascular brain lesions on magnetic resonance imaging.
    Eur Heart J. 2025 Aug 29:ehaf550. doi: 10.1093.
    PubMed         Abstract available

  12. SEGAN L, Kistler PM, Nanayakkara S, Taylor A, et al
    Catheter ablation vs rate control in atrial fibrillation with left ventricular systolic dysfunction and fibrosis: the CAMERA-MRI II trial.
    Eur Heart J. 2025 Aug 29:ehaf604. doi: 10.1093.
    PubMed        

  13. SABA L
    Cerebral signatures of cardiovascular disease: distinct brain lesion patterns in atrial fibrillation and atherosclerosis.
    Eur Heart J. 2025 Aug 29:ehaf551. doi: 10.1093.
    PubMed        


    Heart

  14. JEONG JH, Kim H, Hwang SH, Seo CO, et al
    Genotype and arrhythmic risk in patients with apical hypertrophic cardiomyopathy.
    Heart. 2025 Apr 7:heartjnl-2024-325218. doi: 10.1136/heartjnl-2024-325218.
    PubMed         Abstract available


    Int J Cardiol

  15. XU X, Liu Z, Liu Z, Li Z, et al
    Increased sympathetic outflow induced by ventromedial hypothalamic nucleus activation aggravates cardiac electrophysiology disturbance after myocardial ischemia-reperfusion injury.
    Int J Cardiol. 2025;439:133634.
    PubMed         Abstract available


    J Am Coll Cardiol

  16. WEE SB, Kang DY, Cho MS, Kim MJ, et al
    Long-Term Antithrombotic Therapy in Patients With Atrial Fibrillation and Prior PCI: Insights From EPIC-CAD Trial.
    J Am Coll Cardiol. 2025 Aug 19:S0735-1097(25)07258.
    PubMed        


    J Cardiovasc Electrophysiol

  17. MANGOLD KE, Johnson L, Deshmukh A
    AI to the Rescue: Fighting Atrial Fibrillation With Code.
    J Cardiovasc Electrophysiol. 2025 Aug 27. doi: 10.1111/jce.70084.
    PubMed        


    J Interv Card Electrophysiol

  18. TAN JL, Chirinos J, Patel D, Jagasia D, et al
    Intracardiac echocardiography for left ventricular diastolic function assessment during atrial fibrillation ablation.
    J Interv Card Electrophysiol. 2025 Aug 27. doi: 10.1007/s10840-025-02110.
    PubMed         Abstract available

  19. SASAKI T, Hojo R, Yamaoka K, Kujiraoka H, et al
    Atrial fibrillation ablation with a bidirectional block of the left atrial band.
    J Interv Card Electrophysiol. 2025 Aug 27. doi: 10.1007/s10840-025-02114.
    PubMed        


    N Engl J Med

  20. JONS C, Zheng C, Winslow UCG, Danielsen EM, et al
    Increasing the Potassium Level in Patients at High Risk for Ventricular Arrhythmias.
    N Engl J Med. 2025 Aug 29. doi: 10.1056/NEJMoa2509542.
    PubMed         Abstract available


    PLoS One

  21. TATEISHI R, Miyazaki S, Yamao K, Negishi M, et al
    Evaluation of continuous arrhythmia monitoring using an implantable loop recorder in heart failure patients with a reduced ejection fraction: The LINQ2-HF trial rationale and protocol.
    PLoS One. 2025;20:e0321604.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.